Friday Aug 15
StemCells, Inc: Short-Term Noise Creates Another Buying Opportunity
Since rallying from positive trial results for spinal cord injury and AMD, STEM's stock price has taken a hit from non-trial related issues.
StemCells' (STEM) CEO Martin McGlynn on Q2 2014 Results - Earnings Call Transcript
Good day ladies and gentleman and welcome to the StemCells' Second Quarter 2014 Earnings Conference Call.
StemCells Inc. Reports Second Quarter 2014 Financial Results And Provides Business Update
StemCells, Inc. , a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research and drug discovery, today provided a business update and reported financial results for the second quarter ended June 30, 2014.
Stemcells (STEM) Scheduled to Post Earnings on Tuesday
Stemcells is scheduled to post its quarterly earnings results on Tuesday, August 12th.
StemCells Inc. Announces Webcast To Discuss Second Quarter 2014 Financial Results
StemCells, Inc. , a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research and drug discovery, announced today that it will release financial results for the second quarter ended June 30, 2014 after the market close on Tuesday, August 12. StemCells will host a conference ... (more)
Los Angeles Times
California stem cell agency head takes stand on 'personal ethics'
Alan Trounson, former president of the California Institute for Regenerative Medicine, took a board position with StemCells Inc., a company that had received state agency funding, seven days after leaving his position at CIRM.
New stem cell agency boss: I won't take job, gifts or travel from grantees
Randy Mills, left, is the newly appointed president and CEO of the California Institute for Regenerative Medicine.